TuHURA Biosciences Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | +62.2% | +47.0% | -33.3% | -38.8% | +220.0% | +1,089.7% | -2.0% | -52.5% | -34.2% | -38.9% | |
| – | – | – | – | – | – | – | – | -66.7% | +119.4% | +309.0% | +228.0% | |
| – | -122.3% | – | – | +96.5% | -57.1% | -644.4% | – | – | -68.8% | +575.0% | -195.8% | |
| – | -100.0% | -75.0% | +985,084,900.0% | -100.0% | -100.0% | – | -59.0% | +1,006.0% | +118.4% | -26.9% | +31.4% | |
| – | – | +25.0% | -39.6% | – | – | – | -100.3% | +1,006.0% | +3,474.9% | +366.7% | -77.9% | |
| – | +33.3% | +0.0% | +0.0% | +0.0% | -4.3% | +0.0% | +0.0% | +0.0% | -25.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | – | -100.0% | – | |
| – | – | – | – | – | – | – | – | -219.0% | – | +964.0% | -97.8% | |
| – | +1,028.3% | -11.5% | +9.2% | -56.0% | +62.0% | +294.5% | -72.9% | +130.7% | -83.6% | +1,019.2% | -33.1% | |
| – | – | -90.3% | -243.2% | – | – | – | -94.1% | +1,721.8% | -221.6% | – | -200.5% | |
| – | – | – | – | – | – | – | – | – | – | – | – |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.